Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2022-11-27 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于2019 年限制性股票激励计划第三个解除限售期解除限售股份上市流通的提示性公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the third unlocking period of restricted shares under the 2019 restricted stock incentive plan of the company 西藏易明西雅医药科技股份有限公司. It includes information about the number of shares unlocked, the approval process, performance conditions, individual performance assessments, and changes in shareholding structure. The document is not a full financial report, earnings release, or management discussion, but rather a specific announcement about share unlocking and related corporate actions. It does not contain financial statements or comprehensive financial data but focuses on share incentive plan details and related approvals. This fits best under the category of Transaction in Own Shares (POS), as it deals with the unlocking and listing of restricted shares, which is a form of share capital change related to share incentives and repurchases.
2022-11-27 Chinese
【易明医药】2019年限制性股票第三次解除限售的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2019 restricted stock incentive plan of a company, specifically about the third unlocking of restricted shares. It contains detailed legal analysis, references to company board and shareholder meetings, audit reports, and compliance with regulatory requirements. It is not a financial report, earnings release, or a general announcement but a specialized legal opinion related to stock incentive plans and share unlocking. This type of document fits best under the category of Regulatory Filings (RNS) as it is a legal compliance document and does not constitute an annual report, audit report, or other financial report types.
2022-11-20 Chinese
独立董事关于第三届董事会第九次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding matters discussed at the ninth meeting of the third board of directors of a company. It references compliance with governance rules and legal regulations, and specifically addresses the approval of lifting restrictions on shares under a stock incentive plan. The document is a formal opinion related to board decisions and governance matters, not a full financial report or earnings release. It is not a report publication announcement or certification but a governance-related statement. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board-related decisions and management matters.
2022-11-20 Chinese
关于2019 年限制性股票激励计划第三个解除限售期部分限制性股票解除限售的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the partial lifting of restrictions on restricted stock under the company's 2019 restricted stock incentive plan. It details the approval process, conditions for lifting restrictions, performance targets, and the number of shares involved. It includes board and supervisory committee opinions, independent director opinions, and legal opinions. The document is a formal announcement about a specific corporate action related to stock incentives, not a full financial report or earnings release. It does not contain financial statements or comprehensive financial data but focuses on stock incentive plan details and related approvals. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement about stock incentive plan implementation and related corporate governance matters.
2022-11-20 Chinese
第三届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the ninth meeting of the third Supervisory Board of the company. It details the meeting attendance, the agenda item about the lifting of restrictions on certain restricted stocks under an incentive plan, and the voting results. There is no financial data, no detailed report, no earnings or audit information, and no mention of a report being attached or published. The document is a corporate governance announcement related to supervisory board decisions and internal approvals. This fits best under Board/Management Information (MANG), as it concerns internal governance and supervisory board resolutions rather than a full report or financial disclosure.
2022-11-20 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's third board of directors' ninth meeting. It includes details about the meeting date, attendance, voting results on a stock incentive plan, and references to related disclosures. There is no financial data or comprehensive report content, but rather a summary of board decisions and procedural compliance. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and focused on board meeting resolutions, not a full report or financial statement.
2022-11-20 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.